Safety and Efficacy of CD10367 in Psoriasis Vulgaris
Clinical trial NCT03025282 · COMPLETED
Trial details
- NCT number
- NCT03025282
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-03
- Primary completion
- 2017-03-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.